REGN Competitors & Alternatives
Compare Regeneron Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
REGN
Main Stock$762.63
Tradestie Score
58
Market Cap
$63.59B
P/E Ratio
17.0
Revenue Growth
0.2%
Analyst Upside
+8.0%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals Inc
|
$477.10
|
$103.64B | 28.7 | 49 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$205.52
|
$60.38B | 71.8 | 43 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$853.82
|
$46.96B | 33.7 | 57 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$316.01
|
$36.81B | 74.0 | 53 | Compare |
|
INSM
Insmed, Inc.
|
$98.60
|
$31.13B | - | 47 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$90.58
|
$24.57B | - | 51 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$202.95
|
$22.61B | 36.9 | 55 | Compare |
|
GMAB
Genmab A/S ADS
|
$28.87
|
$19.56B | 21.7 | 50 | Compare |
|
INCY
Incyte Genomics Inc
|
$119.52
|
$16.93B | 16.2 | 59 | Compare |
|
ILMN
Illumina Inc
|
$205.10
|
$15.72B | 35.5 | 59 | Compare |
More REGN Analysis
Data updated: Aug 02, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry